378 related articles for article (PubMed ID: 23427056)
21. Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.
Lei T; Liang Z; Li F; Tang C; Xie K; Wang P; Dong X; Shan S; Jiang M; Xu Q; Luo E; Shen G
Bone; 2018 Mar; 108():10-19. PubMed ID: 29229438
[TBL] [Abstract][Full Text] [Related]
22. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
[TBL] [Abstract][Full Text] [Related]
23. The bone-preserving effects of exendin-4 in ovariectomized rats.
Sun HX; Lu N; Liu DM; Zhao L; Sun LH; Zhao HY; Liu JM; Tao B
Endocrine; 2016 Feb; 51(2):323-32. PubMed ID: 26109471
[TBL] [Abstract][Full Text] [Related]
24. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.
Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C
Bone; 2007 Mar; 40(3):723-9. PubMed ID: 17081815
[TBL] [Abstract][Full Text] [Related]
25. Circadian rhythm affects the preventive role of pulsed electromagnetic fields on ovariectomy-induced osteoporosis in rats.
Jing D; Shen G; Huang J; Xie K; Cai J; Xu Q; Wu X; Luo E
Bone; 2010 Feb; 46(2):487-95. PubMed ID: 19782781
[TBL] [Abstract][Full Text] [Related]
26. [Changes of urinary deoxypyridinoline crosslink/creatinine in rats after ovariectomy and anti-osteoporotic intervention].
Hu YY; Xia WB; Liu HC; Meng XW; Zhou XY; Xing XP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):271-4. PubMed ID: 12905738
[TBL] [Abstract][Full Text] [Related]
27. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
28. Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats.
Xu M; Dick IM; Day R; Randall D; Prince RL
Am J Chin Med; 2003; 31(1):87-101. PubMed ID: 12723758
[TBL] [Abstract][Full Text] [Related]
29. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.
Nuche-Berenguer B; Moreno P; Portal-Nuñez S; Dapía S; Esbrit P; Villanueva-Peñacarrillo ML
Regul Pept; 2010 Jan; 159(1-3):61-6. PubMed ID: 19586609
[TBL] [Abstract][Full Text] [Related]
30. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
[TBL] [Abstract][Full Text] [Related]
31. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
32. [Effects of Dioscorea septemloba on bone metabolism in ovariectomized rats].
Xing GS; Lou JS; Wang ZB; Yu SL; Wang Y; Sheng L
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1909-13. PubMed ID: 18051905
[TBL] [Abstract][Full Text] [Related]
33. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
Ostrowska Z; Kos-Kudla B; Swietochowska E; Marek B; Kajdaniuk D; Górski J
Neuro Endocrinol Lett; 2001 Apr; 22(2):129-36. PubMed ID: 11335889
[TBL] [Abstract][Full Text] [Related]
35. Correlation between salivary and serum markers of bone turnover in osteopenic rats.
Pellegrini GG; Gonzales CM; Somoza JC; Friedman SM; Zeni SN
J Periodontol; 2008 Jan; 79(1):158-65. PubMed ID: 18166106
[TBL] [Abstract][Full Text] [Related]
36. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
37. Increase in bone mass and bone strength by Sambucus williamsii HANCE in ovariectomized rats.
Xie F; Wu CF; Zhang Y; Yao XS; Cheung PY; Chan AS; Wong MS
Biol Pharm Bull; 2005 Oct; 28(10):1879-85. PubMed ID: 16204939
[TBL] [Abstract][Full Text] [Related]
38. Curculigo orchioides, a traditional Chinese medicinal plant, prevents bone loss in ovariectomized rats.
Cao DP; Zheng YN; Qin LP; Han T; Zhang H; Rahman K; Zhang QY
Maturitas; 2008 Apr; 59(4):373-80. PubMed ID: 18468819
[TBL] [Abstract][Full Text] [Related]
39. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
[TBL] [Abstract][Full Text] [Related]
40. Cross-sectional evaluation of bone metabolism in men.
Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
